Myositis is a disorder in which the immune system attacks the muscles. It is hoped that this new treatment may help improve the symptoms of this disease.

Research Objectives

Status

Current

Recruitment

Open

Patient Group

Idiopathic Inflammatory Myopathy/Myositis Status: Current

Study location

Wesley Research Institute

Phase

3

Study type

Industry Sponsored

Sponsors: Argenx BV (global) and ICON Clinical Research Pty Ltd (Local)

    Lead investigator    
            Dr Daman Langguth        

        Clinical trial coordinator		
				Venita Bali			

Technical title

A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathies

About this research project

The research project is testing a new treatment for Active Idiopathic Inflammatory Myopathy. This is a disorder in which the immune system attacks the muscles. This leads to muscle weakness and may affect other organs of the body.

The potential new treatment being tested is called efgartigimod (also called ARGX113). It is hoped that efgartigimod may help improve the symptoms of myositis.

Latest News

Webinar- Navigating Gluten Exposure Together

Watch the latest coeliac disease webinar, valuable insights into the biological response to gluten ingestion, the effects of accidental gluten exposure, and provided practical, real‑world strategies for dining out, travelling, and socialising with confidence and safety.

Queensland claims world-first Chair in Spatial Medicine

In a landmark move in diagnosing and treating chronic disease, Queensland has unveiled the world’s first Chair in Spatial Medicine – a prestigious, philanthropically-funded research leadership position appointed to Associate Professor Arutha Kulasinghe.

Gluten Threshold Study Findings

WRI researchers have made a groundbreaking discovery showing that even extremely small amounts of gluten can trigger measurable immune activation in people with treated coeliac disease – findings that could help refine international food labelling standards.

1 2 3 … 34 Next »

Rare Diseases

Testing treatments to improve symptoms of Myositis